Multiple Myeloma Archives - Curetalks

Off-the-shelf Immune Drug for Aggressive Multiple Myeloma: Teclistamab

U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for teclistamab in the treatment of relapsed or refractory multiple myeloma.…

Nov 03, 2021, 12:00 pm 0 Listen

Goals and challenges of developing a patient focused myeloma center of excellence

The multiple myeloma treatment field has undergone several changes over the past 10-20 years. The average overall survival has changed from 1-3 years…

Sep 08, 2021, 03:15 pm 1 Listen